Kodiak Sciences (KOD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $85.75, -2.69% vs the prior close of $88.12.
- Volume 1.12M shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KOD dips 2.7% to $85.75. Closed at $85.75, -2.69% vs the prior close of $88.12. Day range $85.20–$89.78, opened at $87.18.
KOD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KOD dips 2.7% to $85.75
- Closed at $85.75, -2.69% vs the prior close of $88.12. Day range $85.20–$89.78, opened at $87.18.
- Volume was 1.12M shares, 0.6x its 50-day average of 1.96M — lighter than usual.
- Price is +60.0% vs its 50-day average ($53.61) and +120.8% vs its 200-day average ($38.83).
- 52-week range $13.95–$104.00; today's close sits at 80% of that range, 17.5% below the 52-week high.
Oct 15, 2026 — KOD jumps 8.7% to $88.12
- Closed at $88.12, +8.67% vs the prior close of $81.09. Day range $79.06–$88.50, opened at $81.30.
- Volume was 1.39M shares, 0.7x its 50-day average of 1.95M.
- Price is +66.9% vs its 50-day average ($52.80) and +128.6% vs its 200-day average ($38.54).
- 52-week range $12.64–$104.00; today's close sits at 83% of that range, 15.3% below the 52-week high.
Oct 14, 2026 — KOD slides 11.5% to $81.09, 3 down days in a row
- Closed at $81.09, -11.50% vs the prior close of $91.63. Day range $80.14–$90.62, opened at $90.62.
- Volume was 2.41M shares, 1.3x its 50-day average of 1.91M.
- Price is +56.2% vs its 50-day average ($51.91) and +112.0% vs its 200-day average ($38.24).
- 52-week range $10.94–$104.00; today's close sits at 75% of that range, 22.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — KOD slides 7.7% to $91.63
- Closed at $91.63, -7.69% vs the prior close of $99.26. Day range $91.27–$99.55, opened at $99.29.
- Volume was 1.54M shares, 0.8x its 50-day average of 1.89M.
- Price is +79.2% vs its 50-day average ($51.15) and +141.2% vs its 200-day average ($37.99).
- 52-week range $10.94–$104.00; today's close sits at 87% of that range, 11.9% below the 52-week high.
Oct 12, 2026 — KOD dips 0.6% to $99.26
- Closed at $99.26, -0.61% vs the prior close of $99.87. Day range $97.02–$103.27, opened at $100.08.
- Volume was 1.32M shares, 0.7x its 50-day average of 1.87M.
- Price is +98.1% vs its 50-day average ($50.11) and +163.4% vs its 200-day average ($37.69).
- 52-week range $10.94–$104.00; today's close sits at 95% of that range, 4.6% below the 52-week high.
Oct 9, 2026 — KOD jumps 6.0% to $99.87, a 52-week high
- Closed at $99.87, +5.95% vs the prior close of $94.26. Day range $93.70–$100.33, opened at $94.97.
- Volume was 1.73M shares, 0.9x its 50-day average of 1.85M.
- Price is +104.0% vs its 50-day average ($48.96) and +167.6% vs its 200-day average ($37.33).
- 52-week range $10.94–$104.00; today's close sits at 96% of that range, 4.0% below the 52-week high.
Oct 8, 2026 — KOD jumps 3.5% to $94.26
- Closed at $94.26, +3.49% vs the prior close of $91.08. Day range $89.54–$94.95, opened at $90.01.
- Volume was 1.53M shares, 0.8x its 50-day average of 1.83M.
- Price is +97.2% vs its 50-day average ($47.81) and +155.0% vs its 200-day average ($36.97).
- 52-week range $10.94–$104.00; today's close sits at 90% of that range, 9.4% below the 52-week high.
Oct 7, 2026 — KOD dips 1.4% to $91.08, 4 down days in a row
- Closed at $91.08, -1.36% vs the prior close of $92.34. Day range $89.91–$94.25, opened at $91.74.
- Volume was 1.31M shares, 0.7x its 50-day average of 1.82M.
- Price is +94.9% vs its 50-day average ($46.72) and +148.7% vs its 200-day average ($36.63).
- 52-week range $10.94–$104.00; today's close sits at 86% of that range, 12.4% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — KOD dips 1.6% to $92.34, 3 down days in a row
- Closed at $92.34, -1.57% vs the prior close of $93.81. Day range $89.70–$95.54, opened at $92.86.
- Volume was 1.48M shares, 0.8x its 50-day average of 1.80M.
- Price is +102.0% vs its 50-day average ($45.71) and +154.3% vs its 200-day average ($36.31).
- 52-week range $10.94–$104.00; today's close sits at 87% of that range, 11.2% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — KOD dips 0.7% to $93.81 on 1.9x normal volume
- Closed at $93.81, -0.68% vs the prior close of $94.45. Day range $87.58–$96.64, opened at $92.86.
- Volume was 3.23M shares, 1.9x its 50-day average of 1.75M — unusually heavy trading.
- Price is +109.9% vs its 50-day average ($44.70) and +160.7% vs its 200-day average ($35.98).
- 52-week range $10.94–$104.00; today's close sits at 89% of that range, 9.8% below the 52-week high.
Oct 2, 2026 — KOD slides 4.1% to $94.45
- Closed at $94.45, -4.07% vs the prior close of $98.46. Day range $88.63–$98.95, opened at $98.95.
- Volume was 2.67M shares, 1.6x its 50-day average of 1.70M.
- Price is +116.4% vs its 50-day average ($43.65) and +165.1% vs its 200-day average ($35.63).
- 52-week range $10.94–$104.00; today's close sits at 90% of that range, 9.2% below the 52-week high.
KOD latest news & SEC filings
Every SEC filing by or about KOD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 186 shares at $86.72 (≈$16.13K) on Sep 28, 2026; now holds 1,629,628
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 3,114 shares at $86.72 (≈$270.05K) on Sep 28, 2026; now holds 19,519,021
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 957 shares at $86.81 (≈$83.08K) on Sep 28, 2026; now holds 1,630,585
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 16,036 shares at $86.81 (≈$1.39M) on Sep 28, 2026; now holds 19,535,057
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 3,790 shares at $86.94 (≈$329.51K) on Sep 28, 2026; now holds 1,634,375
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 63,539 shares at $86.94 (≈$5.52M) on Sep 28, 2026; now holds 19,598,596
- …plus 16 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 534 shares at $79.40 (≈$42.40K) on Sep 28, 2026; now holds 1,606,426
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 8,956 shares at $79.40 (≈$711.15K) on Sep 28, 2026; now holds 19,130,090
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 17 shares at $79.63 (≈$1.35K) on Sep 28, 2026; now holds 1,606,443
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 283 shares at $79.63 (≈$22.54K) on Sep 28, 2026; now holds 19,130,373
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 884 shares at $79.71 (≈$70.46K) on Sep 28, 2026; now holds 1,607,327
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 14,827 shares at $79.71 (≈$1.18M) on Sep 28, 2026; now holds 19,145,200
- …plus 24 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 856 shares at $61.21 (≈$52.40K) on Sep 28, 2026; now holds 1,561,270
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 14,344 shares at $61.21 (≈$878.00K) on Sep 28, 2026; now holds 18,373,116
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 2,666 shares at $61.63 (≈$164.29K) on Sep 28, 2026; now holds 1,563,936
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 44,690 shares at $61.63 (≈$2.75M) on Sep 28, 2026; now holds 18,417,806
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 243 shares at $62.96 (≈$15.30K) on Sep 28, 2026; now holds 1,564,179
- Baker Bros. Advisors Lp & 667, L.P. & Baker Bros. Advisors (Gp) Llc & Baker Brothers Life Sciences Lp & Baker Felix & Baker Julian bought 4,067 shares at $62.96 (≈$256.07K) on Sep 28, 2026; now holds 18,421,873
- …plus 24 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Perlroth Victor converted options/RSUs into 600,000 shares at $5.38 (≈$3.23M) on Sep 25, 2026; now holds 2,995,538
- Perlroth Victor converted options/RSUs into 365,840 shares at $2.49 (≈$910.94K) on Sep 25, 2026; now holds 3,361,378
- Perlroth Victor converted options/RSUs into 314,684 shares at $3.95 (≈$1.24M) on Sep 25, 2026; now holds 3,676,062
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$65.64M (prior year -$54.31M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.05 (prior year -$1.03) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade KOD
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 31, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 12.77% (largest 178.0%). That is a volatile stock.
- Liquidity: about 3.97M shares (≈$340.31M) trade per day on average.
- 52-week position: $85.75 vs a range of $13.95–$104.00 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: L.P. 667, bought 1,416 shares on Sep 29, 2026.
- Latest filings: 8-K Sep 28, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 62.85M shares outstanding (Aug 6, 2026), +19.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
KOD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 87.18 | 89.78 | 85.20 | 85.75 | 1.12M |
| Oct 15, 2026 | 81.30 | 88.50 | 79.06 | 88.12 | 1.39M |
| Oct 14, 2026 | 90.62 | 90.62 | 80.14 | 81.09 | 2.41M |
| Oct 13, 2026 | 99.29 | 99.55 | 91.27 | 91.63 | 1.54M |
| Oct 12, 2026 | 100.08 | 103.27 | 97.02 | 99.26 | 1.32M |
| Oct 9, 2026 | 94.97 | 100.33 | 93.70 | 99.87 | 1.73M |
| Oct 8, 2026 | 90.01 | 94.95 | 89.54 | 94.26 | 1.53M |
| Oct 7, 2026 | 91.74 | 94.25 | 89.91 | 91.08 | 1.31M |
| Oct 6, 2026 | 92.86 | 95.54 | 89.70 | 92.34 | 1.48M |
| Oct 5, 2026 | 92.86 | 96.64 | 87.58 | 93.81 | 3.23M |
| Oct 2, 2026 | 98.95 | 98.95 | 88.63 | 94.45 | 2.67M |
| Oct 1, 2026 | 95.41 | 104.00 | 93.95 | 98.46 | 3.79M |
| Sep 30, 2026 | 93.83 | 98.80 | 88.48 | 94.80 | 4.92M |
| Sep 29, 2026 | 87.20 | 93.14 | 83.64 | 91.12 | 6.05M |
| Sep 28, 2026 | 61.71 | 95.77 | 60.49 | 89.92 | 38.55M |
| Sep 25, 2026 | 33.03 | 33.71 | 31.00 | 32.35 | 2.28M |
| Sep 24, 2026 | 30.90 | 33.78 | 29.81 | 33.22 | 1.29M |
| Sep 23, 2026 | 34.10 | 34.48 | 30.80 | 31.52 | 1.05M |
| Sep 22, 2026 | 32.71 | 34.45 | 32.46 | 33.80 | 1.04M |
| Sep 21, 2026 | 33.04 | 33.34 | 32.00 | 32.42 | 666.20K |
About Kodiak Sciences
Kodiak Sciences (KOD) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in PALO ALTO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1468748.
KOD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| L.P. 667, | Director | Sep 30, 2026 |
| Bros. Advisors Lp Baker | Director | Sep 30, 2026 |
| Felix Baker | Director | Sep 30, 2026 |
| Julian Baker | Director | Sep 30, 2026 |
| Bros. Advisors (Gp) Llc Baker | Director | Sep 30, 2026 |
| Brothers Life Sciences Lp Baker | Director | Sep 30, 2026 |
| Charles A Bancroft | Director | Jul 2, 2026 |
| Bassil I Dahiyat | Director | Jul 2, 2026 |
| Richard S Levy | Director | Jul 2, 2026 |
| Victor Perlroth | Chairman and CEO | Sep 29, 2026 |
| Robert Profusek | Director | Jul 2, 2026 |
| Taiyin Yang | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John A. Borgeson | Chief Financial Officer | Jul 17, 2026 |
| Victor Perlroth | Chairman and CEO | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | L.P. 667, | Buy | 1,416 | $85.89 |
| Sep 29, 2026 | L.P. 667, | Buy | 619 | $84.24 |
| Sep 29, 2026 | L.P. 667, | Buy | 10,381 | $84.24 |
| Sep 29, 2026 | L.P. 667, | Buy | 1,195 | $85.40 |
| Sep 29, 2026 | L.P. 667, | Buy | 20,031 | $85.40 |
| Sep 29, 2026 | L.P. 667, | Buy | 84 | $85.89 |
| Sep 29, 2026 | L.P. 667, | Buy | 1,416 | $85.89 |
| Sep 29, 2026 | L.P. 667, | Buy | 619 | $84.24 |
| Sep 29, 2026 | L.P. 667, | Buy | 10,381 | $84.24 |
| Sep 29, 2026 | L.P. 667, | Buy | 1,195 | $85.40 |
| Sep 29, 2026 | L.P. 667, | Buy | 20,031 | $85.40 |
| Sep 29, 2026 | L.P. 667, | Buy | 84 | $85.89 |
| Sep 29, 2026 | Bros. Advisors Lp Baker | Buy | 1,416 | $85.89 |
| Sep 29, 2026 | Bros. Advisors Lp Baker | Buy | 619 | $84.24 |
| Sep 29, 2026 | Bros. Advisors Lp Baker | Buy | 10,381 | $84.24 |
KOD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-229.97M | -4.32 | $-136.01M |
| Dec 31, 2024 | — | $-176.21M | -3.35 | $-117.32M |
| Dec 31, 2023 | — | $-260.49M | -4.97 | $-154.18M |
| Dec 31, 2022 | — | $-333.82M | -6.39 | $-206.46M |
| Dec 31, 2021 | — | $-266.99M | -5.16 | $-182.27M |
Latest balance sheet: total assets $256.81M, total liabilities $195.72M, cash $125.90M (as of Jun 30, 2026).
KOD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $39.98 |
| May 7, 2026 | 8-K Item 2.02 (results) | $43.68 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $38.12 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $18.87 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $8.62 |
| May 14, 2025 | 8-K Item 2.02 (results) | $3.94 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $3.06 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $5.30 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)Repligen (RGEN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KOD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.